Biggest News Aggregation in the World
📰 Nasdaq Coll News

Page 4 - Nasdaq Coll News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Coll. Real-time updates on events, politics, business and more.

ObsEva (NASDAQ:OBSV) and Collegium Pharmaceutical (NASDAQ:COLL) Critical Survey

Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) and ObsEva (NASDAQ:OBSV – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership. Risk & Volatility Collegium Pharmaceutical has a beta of 0.81, […]
Ernest Loumaye Michael Thomas Heffernan Collegium Pharmaceutical Inc Collegium Pharmaceutical Get Rating Given Obseva

Collegium Pharmaceutical (NASDAQ:COLL) Lifted to "Buy" at StockNews.com

StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) from a hold rating to a buy rating in a research note issued to investors on Saturday morning. A number of other equities analysts have also recently issued reports on COLL. Piper Sandler dropped their price objective on Collegium Pharmaceutical from $37.00 to $35.00 in […]
United States Colleen Tupper Joseph Ciaffoni Piper Sandler Collegium Pharmaceutical Inc American Century Companies Inc

Martingale Asset Management L P Has $653,000 Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Martingale Asset Management L P raised its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) by 15.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 28,168 shares of the specialty pharmaceutical company’s stock after purchasing an additional 3,855 shares during the quarter. Martingale Asset Management L P’s holdings in Collegium Pharmaceutical were worth […]
United States United Kingdom Joseph Ciaffoni Colleen Tupper Piper Sandler Exchange Commission

Collegium Pharmaceutical (NASDAQ:COLL) Trading Down 2.8% Following Insider Selling

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) traded down 2.8% on Friday after an insider sold shares in the company. The company traded as low as $21.72 and last traded at $21.72. 19,418 shares changed hands during mid-day trading, a decline of 95% from the average session volume of 429,588 shares. The stock had previously […]
United States Colleen Tupper Joseph Ciaffoni Piper Sandler Maverick Capital Ltd Securities Exchange Commission

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) CEO Sells $684,834.90 in Stock

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) CEO Joseph Ciaffoni sold 31,271 shares of the business’s stock in a transaction on Tuesday, May 30th. The stock was sold at an average price of $21.90, for a total value of $684,834.90. Following the completion of the sale, the chief executive officer now directly owns 368,816 shares […]
Piper Sandler Joseph Ciaffoni Needham Company Altshuler Shaham Ltd Securities Exchange Commission Us Capital Wealth Advisors
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Collegium Pharmaceutical (NASDAQ:COLL) Cut to "Hold" at StockNews.com

StockNews.com downgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) from a buy rating to a hold rating in a research note released on Tuesday morning. Other equities research analysts also recently issued research reports about the stock. Piper Sandler reduced their price objective on shares of Collegium Pharmaceutical from $37.00 to $35.00 in a […]
Scott Dreyer Colleen Tupper Piper Sandler Needham Company Blackrock Inc Securities Exchange Commission

Collegium Pharmaceutical (NASDAQ:COLL) Downgraded by StockNews.com

StockNews.com cut shares of Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) from a buy rating to a hold rating in a report published on Tuesday. COLL has been the topic of a number of other reports. Piper Sandler decreased their target price on shares of Collegium Pharmaceutical from $37.00 to $35.00 in a research note on […]
United Kingdom Scott Dreyer Piper Sandler Colleen Tupper Marshall Wace Collegium Pharmaceutical Inc
Source: wkrb13.com

Collegium Pharmaceutical (NASDAQ:COLL) Lowered to Hold at StockNews.com

Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday. Other equities research analysts have also recently issued research reports about the company. Needham & Company LLC reaffirmed a “buy” rating and set a $35.00 target […]
Piper Sandler Scott Dreyer Colleen Tupper Collegium Pharmaceutical Company Profile Geode Capital Management Susquehanna International Group

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at StockNews.com

StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) from a hold rating to a buy rating in a report issued on Monday morning. Several other analysts have also recently issued reports on COLL. Piper Sandler dropped their price objective on shares of Collegium Pharmaceutical from $37.00 to $35.00 in a research note on […]
Colleen Tupper Shirleyr Kuhlmann Piper Sandler Needham Company Blackrock Inc Collegium Pharmaceutical Inc
Source: wkrb13.com

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) to Post Q1 2023 Earnings of $1.00 Per Share, Jefferies Financial Group Forecasts

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) – Stock analysts at Jefferies Financial Group issued their Q1 2023 earnings per share (EPS) estimates for Collegium Pharmaceutical in a report issued on Tuesday, May 2nd. Jefferies Financial Group analyst G. Santangelo anticipates that the specialty pharmaceutical company will post earnings of $1.00 per share for the […]
United States Joseph Ciaffoni Piper Sandler Colleen Tupper Collegium Pharmaceutical Inc Easterly Investment Partners
Source: wkrb13.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science